Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice

Journal of Neuroscience- United States

doi 10.1523/jneurosci.2131-15.2015

Full Text

Abstract

Available in

Categories

Date

December 16, 2015

Authors

L. M. Kosloski-Bilek

H. E. Gendelman

Publisher

Society for Neuroscience

Related search

MiR-7-1 Potentiated Estrogen Receptor Agonists for Functional Neuroprotection in VSC4.1 Motoneurons

English

Selective V1a Receptor Agonists in Experimental Septic Shock

Intensive Care Medicine

English

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia

Frontiers in Pediatrics

English

Design of Subtype Selective Melatonin Receptor Agonists and Antagonists

Reproduction Nutrition Development

English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer

English

The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia

European Oncology and Haematology

English

Impact of Isotype Selective Estrogen Receptor Agonists on Ovarian Function

Experimental and Clinical Endocrinology and Diabetes

Internal Medicine

English

Antidepressant and Anxiolytic Effects of Selective 5-Ht6 Receptor Agonists in Rats

Psychopharmacology

English